TMCnet News

Cartiva to Present at 36th Annual J.P. Morgan Healthcare Conference
[December 27, 2017]

Cartiva to Present at 36th Annual J.P. Morgan Healthcare Conference


Cartiva, Inc., a medical device company focused on the treatment of osteoarthritis of the extremities, today announced that Tim Patrick, President and Chief Executive Officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. Mr. Patrick is scheduled to present at 8:30 a.m. EST on Wednesday, January 10, 2018.

About Cartiva, Inc.

Based in Alpharetta, Ga., Cartiva, Inc. is a medical device company focused on the treatment of osteorthritis of the extremities. Cartiva's synthetic cartilage is the only FDA-approved biomedical implant that mimics natural cartilage. The company's venture investors include New Enterprise Associates and Windham Venture Partners. Additional information is available on the company's website at www.cartiva.net.





[ Back To TMCnet.com's Homepage ]